Journal Mobile Options
Table of Contents
Vol. 26, No. 6, 2008
Issue release date: December 2008
Section title: Original Paper
Blood Purif 2008;26:555–560
(DOI:10.1159/000178772)

Lipoprotein Lipase 1595 C/G and Hepatic Lipase –480 C/T Polymorphisms – Impact on Lipid Profile in Incident Dialysis Patients

Chmielewski M. · Stenvinkel P. · Luttropp K. · Suliman M.E. · Qureshi A.R. · Carrero J.J. · Barany P. · Heimburger O. · Nordfors L. · Lindholm B.
aDivision of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, bDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; cDepartment of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland; dFaculty of Medicine, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 6/26/2008
Accepted: 9/9/2008
Published online: 12/2/2008

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 3

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: http://www.karger.com/BPU

Abstract

Background: Dyslipidemia is a common complication of chronic kidney disease. Lipoprotein lipase (LPL) 1595 C/G and hepatic lipase (HL) –480 C/T single nucleotide polymorphisms (SNPs) influence lipid profile and predisposition for cardiovascular disease in the general population. The present study was undertaken to clarify the impact of the two polymorphisms on lipid parameters and cardiovascular risk in incident dialysis patients. Methods: LPL 1595 C/G and HL –480 C/T SNPs were evaluated in 293 chronic kidney disease patients close to dialysis initiation. Associations with lipid parameters, presence of cardiovascular disease, and survival were assessed. Results: LPL 1595 C/G SNP was associated with significantly lower triglyceride levels [1.55 (1.00–2.20) vs. 1.90 (1.40–2.48) mM; p < 0.01], while HL –480 C/T polymorphism was associated with increased high density lipoprotein cholesterol concentration [1.30 (1.00–1.60) vs. 1.10 (0.90–1.40) mM; p < 0.05]. Neither of the polymorphisms showed any relationship with patient survival. Conclusions: LPL 1595 C/G and HL –480 C/T polymorphisms affect lipid profile in incident dialysis patients.


  

Author Contacts

Michal Chmielewski, MD, PhD
Division of Renal Medicine and Baxter Novum
Department of Clinical Science, Technology and Intervention
Karolinska University Hospital Huddinge, SE–141 86 Stockholm (Sweden)
Tel. +48 609 639 763, Fax +48 583 461 186, E-Mail chmiel@amg.gda.pl

  

Article Information

B.L. is employed by Baxter Healthcare Inc. and P.S. is a member of the Gambro Scientific Advisory Board.

Received: June 26, 2008
Accepted: September 9, 2008
Published online: December 2, 2008
Number of Print Pages : 6
Number of Figures : 2, Number of Tables : 3, Number of References : 18

  

Publication Details

Blood Purification

Vol. 26, No. 6, Year 2008 (Cover Date: December 2008)

Journal Editor: Ronco C. (Vicenza)
ISSN: 0253–5068 (Print), eISSN: 1421–9735 (Online)

For additional information: http://www.karger.com/BPU


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 6/26/2008
Accepted: 9/9/2008
Published online: 12/2/2008

Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 3

ISSN: 0253-5068 (Print)
eISSN: 1421-9735 (Online)

For additional information: http://www.karger.com/BPU


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.